Literature DB >> 7891423

Low levels of serum apolipoprotein A I and A II in senile dementia.

M Kuriyama1, K Takahashi, T Yamano, Y Hokezu, S Togo, M Osame, T Igakura.   

Abstract

We studied the serum lipoprotein and apolipoprotein profiles in 44 patients with sporadic late-onset Alzheimer's dementia and 43 patients with vascular dementia. The levels of high-density lipoprotein (HDL) cholesterol were lower in both patient groups than in a control group. Apolipoprotein A I and A II levels have decreased in both the patient groups, especially in the vascular dementia group. The HDL-cholesterol levels correlated positively with the level of apolipoprotein A I, but not with the level of apolipoprotein A II. The ratios of apolipoprotein A I/A II have increased in both the patient groups. The apolipoprotein A II levels have disproportionally decreased in the patient groups. The serum apolipoprotein A II may involve the pathological process in the patients with senile dementia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7891423     DOI: 10.1111/j.1440-1819.1994.tb03019.x

Source DB:  PubMed          Journal:  Jpn J Psychiatry Neurol        ISSN: 0912-2036


  17 in total

1.  Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?

Authors:  Nikolaos Scarmeas
Journal:  Am J Epidemiol       Date:  2007-02-13       Impact factor: 4.897

2.  Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis.

Authors:  M A Beydoun; H A Beydoun; Y Wang
Journal:  Obes Rev       Date:  2008-03-06       Impact factor: 9.213

Review 3.  Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.

Authors:  Romina M Uranga; Annadora J Bruce-Keller; Christopher D Morrison; Sun Ok Fernandez-Kim; Philip J Ebenezer; Le Zhang; Kalavathi Dasuri; Jeffrey N Keller
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

4.  Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice.

Authors:  Iliya Lefterov; Nicholas F Fitz; Andrea A Cronican; Allison Fogg; Preslav Lefterov; Ravindra Kodali; Ronald Wetzel; Radosveta Koldamova
Journal:  J Biol Chem       Date:  2010-08-25       Impact factor: 5.157

5.  Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease.

Authors:  Christiane Reitz; Ming-Xin Tang; Nicole Schupf; Jennifer J Manly; Richard Mayeux; José A Luchsinger
Journal:  Arch Neurol       Date:  2010-12

Review 6.  Apolipoproteins and amyloid fibril formation in atherosclerosis.

Authors:  Chai Lean Teoh; Michael D W Griffin; Geoffrey J Howlett
Journal:  Protein Cell       Date:  2011-03-12       Impact factor: 14.870

7.  Impact of plasma lipids and time on memory performance in healthy elderly without dementia.

Authors:  C Reitz; J Luchsinger; M-X Tang; J Manly; R Mayeux
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

8.  Relation of plasma lipids to Alzheimer disease and vascular dementia.

Authors:  Christiane Reitz; Ming-Xin Tang; Jose Luchsinger; Richard Mayeux
Journal:  Arch Neurol       Date:  2004-05

9.  Blood lipid markers are associated with hippocampal viscoelastic properties and memory in humans.

Authors:  Faria Sanjana; Peyton L Delgorio; Lucy V Hiscox; Theodore M DeConne; Joshua C Hobson; Matthew L Cohen; Curtis L Johnson; Christopher R Martens
Journal:  J Cereb Blood Flow Metab       Date:  2020-10-26       Impact factor: 6.200

Review 10.  Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer's Disease: Systematic Review and Meta-Analysis.

Authors:  Marco Zuin; Carlo Cervellati; Alessandro Trentini; Angelina Passaro; Valentina Rosta; Francesca Zimetti; Giovanni Zuliani
Journal:  Diagnostics (Basel)       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.